Background: The study aims were to examine daily associations between marijuana and alcohol use and the extent to which the association differs as a function of cannabis use disorder (CUD) and/or alcohol use disorder (AUD) diagnosis.
M
ARIJUANA, THE MOST used illicit drug in the United States and the world, is frequently used in association with alcohol. Marijuana use is prospectively associated with both heavy drinking and with the development and maintenance of alcohol use disorders (AUDs; Blanco et al., 2016; Weinberger et al., 2016) as well as with the deleterious AUD treatment outcomes (Aharonovich et al., 2005; Mojarrad et al., 2014; Subbaraman, 2016) . Couse of marijuana and alcohol is associated with heavy episodic drinking and AUDs (Bri ere et al., 2011; Midanik et al., 2007; Subbaraman and Kerr, 2015) . Among marijuana users with cannabis use disorder (CUD), there is increased likelihood for development of a comorbid AUD (Agosti et al., 2002; Regier et al., 2014; Stinson et al., 2006) , with nationally representative data indicating that 68% of individuals with current CUD and over 86% of those with a history of CUD meeting criteria for an AUD (Agrawal et al., 2007; Center for Behavioral Health Statistics and Quality, 2016) . Marijuana dependence doubles the risk for long-term persistent alcohol problems (Copeland et al., 2012) , and marijuana-dependent alcohol users are 3 times more likely to develop alcohol dependence than non-marijuana-involved drinkers (Lopez-Quintero et al., 2010) . Co-use (concurrent or simultaneous) of marijuana and heavy alcohol use is linked to a number of behavioral problems (Harrington et al., 2012) with exceptionally heightened risk for impaired driving (Biecheler et al., 2008; Li et al., 2012) , psychiatric comorbidity (Midanik et al., 2007) , and poor clinical treatment outcomes (Staiger et al., 2012) . Importantly, the risk associated with the use of marijuana in combination with alcohol is greater than that from either drug alone (Volkow et al., 2014) . Thus, increased attention has been called to the importance of examining inter-relations among alcohol and marijuana use patterns and the impact of the use of one substance on risk of excessive use of the other (Staiger et al., 2012; Yurasek et al., 2017) .
The majority of the epidemiological studies using individual-level outcomes indicate that marijuana use increases or complements alcohol consumption (reviewed in Subbaraman, 2016) . Similarly, studies of economic policies that reduce access to alcohol or increase the price of alcohol demonstrate complementary reductions in both alcohol and marijuana use (Farrelly et al., 1999; Pacula, 1998; Williams et al., 2004) . However, longitudinal general population studies that mostly used state-level data on marijuana policy (e.g., marijuana decriminalization) suggest marijuana and alcohol can be substitutes (Subbaraman, 2016) . Research with individuals using marijuana for medicinal purposes also indicates that alcohol use is lower or less likely with concurrent marijuana use (Lin et al., 2016; Nunberg et al., 2011) . These findings suggest that individuals who use marijuana for medicinal (but not recreational) purposes may use it as a harm-reduction strategy to substitute for alcohol (Lin et al., 2016; Loflin et al., 2017; Metrik et al., 2018) . Preliminary evidence of alcohol substitution was also noted in a clinical study where controlled abstinence from marijuana was linked with increased alcohol craving and consumption among individuals with AUD (Peters and Hughes, 2010) and also in an experimental study that demonstrated decreased alcohol consumption over time when smoked marijuana was available during an operant task (Mello et al., 1978) . Collectively, this research indicates that marijuana use is strongly linked with alcohol use, although whether marijuana serves as a complement to or substitute for alcohol use remains unclear.
These mixed findings on co-occurrence between alcohol and marijuana use behaviors may reflect methodological limitations of correlational research which precludes causal inference. Similarly, epidemiological and laboratory studies are not designed to determine whether marijuana and alcohol use are linked at the event-level within individuals in a natural setting. The few experimental studies have primarily focused on pharmacokinetic interactions (Ballard and de Wit, 2010; Hartman et al., 2015; Lukas and Orozco, 2001; Lukas et al., 1992) or on performance impairments from combined use of marijuana and alcohol (Chait and Perry, 1994; Heishman et al., 1997; Ramaekers et al., 2011) , and thus offer limited information on marijuana's influence on alcohol consumption. Although several studies have asked respondents to recall their most recent marijuana-alcohol use event (Barrett et al., 2006; Jenkinson et al., 2014; McKetin et al., 2014) , they cannot distinguish different use events within the same person. Therefore, it is critical to use nuanced methods that examine co-use of marijuana and alcohol, such as event or daily level. To our knowledge, there have been only a few event-level studies on the co-occurrence of marijuana and alcohol use. One recent study used ecological momentary assessment (EMA) methods to characterize the context of adolescent simultaneous marijuana and alcohol use, but did not examine event-level associations between the 2 behaviors (Lipperman-Kreda et al., 2017) . Another study examining daily marijuana and alcohol use found that marijuana intoxication was greater on days when participants used any alcohol or had 5 or more alcoholic drinks on 1 occasion (Hughes et al., 2014) . However, whether marijuana use predicted heavy drinking was not examined. Furthermore, neither study examined whether meeting criteria for AUD or CUD moderated the concurrent marijuana and alcohol use. A recent online daily diary study showed evidence for complementary alcohol and marijuana use at both the within-and between-person levels (O'Hara et al., 2016) . However, individuals with coping-oriented patterns of substance use showed evidence of substitution by increasing levels of drinking while decreasing marijuana use.
Heterogeneous samples may have contributed to the mixed findings in research examining marijuana-alcohol associations. For example, marijuana use may be associated with worse drinking outcomes among heavy drinkers, especially those with AUD. For these individuals, learned associations of conjoint use (e.g., urge to drink due to anticipation of increased positive subjective effects or anticipation of anxiety reduction) may be particularly salient. Marijuana also impairs executive control functioning (Desrosiers et al., 2015; Metrik et al., 2012; Ramaekers et al., 2006) , which may already be reduced among chronic heavy drinkers (Ramaekers et al., 2011 (Ramaekers et al., , 2016 . Thus, in individuals with AUD, marijuana use may increase alcohol craving and may result in heavy drinking. Likewise, given that individuals with CUD are known to be at greater risk for problematic drinking (Copeland et al., 2012; Lopez-Quintero et al., 2010) , and CUD and AUD are highly comorbid (Regier et al., 2014; Stinson et al., 2006) , alcohol involvement may be even greater in individuals with the dual diagnoses of CUD and AUD.
This study extends the growing literature on the association of marijuana and alcohol use and use disorders using event-level data to examine daily associations between marijuana and alcohol use in a clinical population with high base rates of use of these substances. The sample was recruited from the Veterans Health Administration (VHA) facility to capitalize on the disproportionately high rates of substance use disorders in veterans relative to the general population (Seal et al., 2011) . Veterans are at increased risk for substance use disorders because of the significantly elevated rates of mental health disorders such as posttraumatic stress disorder and major depressive disorder, which are strongly associated with using alcohol and marijuana specifically to cope with aversive psychological and mood states as well as with sleep disturbance (Metrik et al., 2016) . Returning veterans experience high rates of suicide and impaired psychosocial functioning postdeployment, which further exacerbate the severity of substance use disorders in this vulnerable population (Spelman et al., 2012) . Participants were selected based on co-use of marijuana and alcohol with a full range of marijuana and alcohol involvement (ranging in frequency from occasional to daily use and from nonproblematic to pathological levels of use). As there may be different associations for any use versus level of alcohol use, we examined any alcohol use as well as heavy and moderate levels of drinking. There are 2 main hypotheses of this study. First, we hypothesized that marijuana use (vs. nonuse) on a given day will be associated with greater alcohol consumption (i.e., greater likelihood of heavy drinking, ≥5 (men)/4 (women) drinks, versus moderate drinking (1 to 4/3 drinks); and moderate drinking vs. none) on that day. Second, we examined the potential moderating effects of AUD and CUD diagnosis, as ascertained by the Structured Clinical Interview for DSM (First et al., 2002) , on the marijuana-alcohol relationship. Specifically, we expected that marijuana use on a given day will be associated with heavy alcohol use that day specifically among individuals with a diagnosis of AUD or CUD but not among individuals without these diagnoses. Furthermore, we expected that a dual diagnosis of CUD and AUD would amplify the association between marijuana and alcohol use relative to a single diagnosis of AUD or CUD.
MATERIALS AND METHODS

Sample and Procedure
Data were drawn from a larger prospective study examining marijuana use and affective disorders in returning OEF/OIF/OND veterans who were deployed post 9/11/2001 and who used marijuana at least once in his/her lifetime. Participants were recruited from a VHA facility in the Northeast United States and by utilizing the VHA OEF/OIF/OND Roster, an accruing database of combat veterans who have returned from military service in Iraq and Afghanistan (for details of recruitment procedures, see Metrik et al., 2016) . All participants were residing in a state with medical marijuana laws (i.e., RI, MA, and CT). Veterans were screened for eligibility by telephone and were invited for a baseline visit, at which time they signed informed consent and completed a battery of interview and selfreport assessments. Participants were not required to utilize any of the VHA services in order to participate in the study and, importantly, were told that all information collected as part of this study would be kept confidential, would have no connection to their medical record, and would not affect services they receive at the VHA. The study was approved by the university and local VHA Institutional Review Boards. Participants were compensated $50 upon completion of the study session. Sample demographics are presented in Table 1 . Notably, the vast majority of the sample (94%) was comprised of men.
Measures
Demographic Information. Demographic and background information, such as sex, ethnicity, and marital status, was collected at baseline and verified through the VHA Computerized Patient Record System. Structured Clinical Interview for DSM Non-Patient Edition was used to determine diagnosis of lifetime and past-year DSM-5 CUD and AUD (First et al., 2002) based on endorsement of 2+ of 11 symptoms.
The Timeline Followback (TLFB; Dennis et al., 2004; Sobell and Sobell, 1992) covered the 180 days prior to the visit and was used to determine percent of marijuana use days, alcohol use days (measured in standard drinks, defined as 12 oz. of beer, 5 oz. of wine, or 1.5 oz. 80-proof distilled spirits), heavy drinking days (genderadjusted for 5/4 drinks), other drug (any drug other than marijuana) use days, and tobacco cigarette use days. The TLFB is a calendarassisted structured interview, which provides a way to cue memory to enhance recall accuracy. The TLFB interview is established as a psychometrically sound retrospective method for assessing alcohol use (Sobell and Sobell, 1992) and marijuana use (Dennis et al., 2004) and has been shown to give highly valid estimates of substance use with high levels of agreement with biological measures (Hjorthøj et al., 2012) . TLFB has high test-retest reliability and stability over periods of 180 days (Carey, 1997) and up to 1 year (Sobell and Sobell, 1992) .
Data Analysis
Because data were nested within individuals, multilevel modeling (Raudenbush and Bryk, 2002; Snijders and Bosker, 1999 ) was used to test first 2 hypotheses. R (R Core Team, 2013) was used to conduct all analyses; specifically, ordinal (Christensen, 2015) for nominal cumulative link mixed models was used to examine the prediction of daily alcohol quantity by marijuana use. In order to test the proportional odds assumption, we compared model fit between 2 models: one in which the 3-level drinking variable was treated as an ordinal outcome and another in which it was treated as a nominal outcome. Model comparisons revealed that the less parsimonious model (with nominal outcomes) fits better, suggesting it as the more appropriate model (v 2 (1) = 60.83, p < 0.001). Two dependent variables were calculated from TLFB data: any alcohol use (binary variable: any drinks vs. no drinks) and genderadjusted drinking quantity (no use: 0 drinks, moderate use: 1 to 4 (men)/3 (women) drinks, and heavy use: ≥5/4 drinks). Models included fixed effects of percent of marijuana use days (betweenperson), daily marijuana use (binary), age, sex, any cigarette use (binary), and other drug use (binary), day of the week (binary: weekend or weekday), and random effects for individual. Day of the week was included as a fixed effect given previous studies have identified it as a significant predictor of both alcohol and marijuana use Patrick et al., 2016) . For the model examining moderation by diagnosis, a single diagnostic variable was calculated to categorize individuals into 1 of 4 categories: no diagnosis, CUD, AUD, and dual diagnosis of CUD with AUD. For these analyses, no daily marijuana use and no diagnosis group were designated as reference groups to compare hypothesized effects. Dependent variables, other fixed effects, and random effects remained the same as previously described linear mixed models. Analyses excluding female participants (6%) produced the same findings, and therefore, results for the full sample are presented.
RESULTS
Descriptive Statistics
The data presented here were subset from the original data set to include only individuals (N = 127) who used alcohol and marijuana on at least 1 day in the 180-day TLFB assessment period, resulting in 22,860 daily observations. Table 1 presents sample demographics and substance use descriptive statistics. Across all observations, subjects reported alcohol use on 6,313 days (28%), using marijuana on 9,186 days (40%), using both marijuana and alcohol on 2,052 days (9%), using other drugs on 1,430 days (6%), and smoking cigarettes on 10,152 days (45%). Participants averaged 22.66 moderate drinking days and 15.03 heavy drinking days and 8.98 same-day marijuana and alcohol use days across the 180-day TLFB assessment period. Table 2 displays sample demographics and substance use descriptives as a function of diagnosis (None, AUD, CUD, and comorbid AUD + CUD). Table 3 presents bivariate correlations across individuals and across observations. At the daily level (all TLFB observations across individuals), any marijuana use was associated with any drinking (r = 0.10, p < 0.001) and number of drinks per drinking day (r = 0.09, p < 0.001). At the aggregate level (TLFB observations collapsed across individual and day), marijuana use frequency was significantly associated with drinking frequency (r = 0.24, p < 0.001).
Association Between Marijuana and Alcohol Use
To examine whether marijuana use on any given day predicted extent of alcohol use, we ran the first mixed effects nominal cumulative link model described above, predicting the 3-level drinking variable from any marijuana use, controlling for age, sex, any cigarette use, any drug use, and the day of the week. Analyses (Table 4) revealed that marijuana use on a given day predicted drinking quantity. Specifically, on days where marijuana was used, odds of moderate (1 to 4/3 drinks) compared to no drinking (Est. = 0.48, p < 0.001, OR = 1.61) and heavy (≥5/4 drinks) drinking compared to moderate drinking (Est. = 0.85, p < 0.001, OR = 2.34) were greater.
Association Between Cannabis and Alcohol Use by Alcohol and Cannabis Use Disorder
We conducted an additional nominal cumulative link mixed model to examine whether diagnosis (None, AUD, CUD, and comorbid AUD + CUD) moderated the relationship between marijuana use and drinking quantity. As described above, the model included the main effects of marijuana use on any given day and the diagnostic variable, as well as the interaction between marijuana use and diagnosis (Table 5) , with diagnosis treated as 3 dummy codes (no diagnosis as the reference group). As in the previous model, analyses revealed a main effect of any marijuana use on moderate drinking over no drinking (Est. = 0.36, p = 0.006, A main effect of AUD was also observed on moderate drinking over no drinking (Est. = 2.32, p < 0.001, OR = 10.20), as well as heavy drinking over moderate drinking (Est. = 2.14, p < 0.001, OR = 8.51), compared to those with no diagnosis. A main effect of the combined diagnosis group was also observed on heavy drinking over moderate drinking (Est. = 1.72, p = 0.004, OR = 5.59). No such main effects were observed for CUD. Importantly, there was a significant interaction observed between diagnostic group and marijuana use. Specifically, marijuana use predicted heavy drinking compared to moderate drinking (Est. = 0.65, p = 0.001, OR = 1.91) in those with AUD compared to those with no diagnosis. However, among those with only CUD, marijuana use predicted significantly less heavy drinking compared to moderate drinking (Est. = À1.15, p < 0.001, OR = 0.32). Finally, marijuana use also predicted more heavy drinking compared to moderate drinking (Est. = 0.92, p < 0.001, OR = 2.51) in those with combined AUD and CUD compared to those with no diagnosis. No significant interaction effects were observed for the comparison between moderate use and no use. Figure 1 presents percent of days at each drinking level (none, moderate, and heavy) on marijuana use days versus nonmarijuana use days grouped by diagnosis (None, AUD, CUD, and comorbid AUD + CUD). Overall, results suggested that, relative to those without a diagnosis, among individuals with AUD (alone or with a comorbid CUD), marijuana use at the daily level was associated with higher rates of heavy alcohol use, but not necessarily moderate use.
DISCUSSION
The current study aimed to extend the literature on marijuana and alcohol co-use by examining the role of marijuana use in alcohol consumption among individuals with and without AUD and CUD. The study's aims were to use eventlevel data to examine: (i) the association of marijuana use on any given day with level of alcohol use (any, moderate, heavy drinking) on that day; and (ii) the moderating effects of AUD and CUD diagnoses on the association between marijuana and levels of alcohol use on a given day. Results indicated that on any given day when marijuana was used relative to nonuse days, participants were significantly more likely to drink alcohol than they were to not drink. Importantly, on days when marijuana was used, heavy drinking (≥5/4 drinks for men/women) was more likely than drinking at moderate levels (1 to 4/3 drinks), which was in turn more likely than not drinking at all. Among individuals meeting criteria for AUD with or without CUD, marijuana use on any given day was predictive of heavy drinking levels (relative to moderate or no drinking). In contrast, among individuals with only CUD, marijuana use on any given day was Upper diagonal represents correlations at the daily level (within-subjects), and bottom diagonal represents correlations collapsed across individuals (between-subjects). For correlations across individuals, alcohol, marijuana, drug, and cigarette use were summed for each individuals across 180 TLFB days, DDD = drinks per drinking day. 3-Level drinking = categorical drinking variable for no drinking, moderate drinking (1 to 4/3 drinks for men/women), or heavy drinking (≥5/4 drinks for men/women). Marijuana use = dichotomous (0/1) any marijuana use; Alcohol use = dichotomous (0/1) any alcohol use; Drug use = dichotomous (0/1) for any other illicit drug use. For correlations between 2 binary variables (Alcohol use, any Marijuana use, Drug use, Cigarette use), Spearman rank coefficients were used; for all other correlations, Pearson correlations were calculated. *p < 0.05, **p < 0.01, ***p < 0.001. Threshold coefficients represent contrasts at each level of the nominal drinking outcome, 0 = no drinking, 1 = moderate drinking (1 to 4/3 drinks for men/women), 2 = heavy drinking (≥5/4 drinks for men/women). Lower and Upper CI represent bootstrapped 95% confidence intervals; bolded effects are statistically significant. Predictors in top panel are held constant across thresholds. All effects are within-person at the daily level, with the exception of Age, Sex, and % of marijuana use days, which were betweenperson. associated with reduced likelihood of drinking heavily relative to drinking moderately that day. This is one of the first studies to examine event-level patterns of marijuana and alcohol co-use, and current findings support results from prospective investigations in clinical samples. In a number of studies of individuals engaged in substance use treatment, those who used marijuana at study entry (Mojarrad et al., 2014) , during AUD treatment (Subbaraman et al., 2017) , or postdischarge from psychiatric inpatient treatment (Aharonovich et al., 2005) were observed to have reduced odds of successfully achieving abstinence from alcohol at the end of treatment and 1 year post treatment. Our findings are also consistent with those from general population surveys demonstrating prospective associations between marijuana use and a 2-fold increase in the likelihood of receiving an AUD diagnosis (Blanco et al., 2016) as well as in maintenance of AUD (Weinberger et al., 2016) . To date, no prior study has collected daily marijuana and alcohol use data to specifically examine the impact of marijuana use on the extent of alcohol involvement on a given day. Taken together, our event-level findings and those from prospective studies generally support the complementary role of marijuana in drinking behavior, particularly among those who use alcohol at pathological levels.
The finding that marijuana use was associated with increased alcohol consumption among individuals with Fig. 1 . Interaction of diagnostic group and marijuana use on alcohol use. Vertical axis represents percent of days at each drinking level (None = 0 drinks, Moderate = 1 to 4 drinks for men (1 to 3 drinks for women); Heavy = ≥5 drinks for men (≥4 drinks for women)), for each group on the horizontal axis. None = no diagnosis and nonmarijuana use days, None-MJ = no diagnosis on marijuana use days; AUD = AUD diagnosis only on nonmarijuana use days; AUD-MJ = AUD diagnosis on marijuana use days; CUD = CUD diagnosis on nonmarijuana use days; CUD-MJ = CUD diagnosis on marijuana use days; AUDCUD = AUD + CUD diagnosis on nonmarijuana use days; AUDCUD-MJ = AUD + CUD diagnosis on marijuana use days. Threshold coefficients represent contrasts at each level of the nominal drinking outcome, 0 = no drinking, 1 = moderate drinking (1 to 4/3 drinks for men/women), 2 = heavy drinking (≥5/4 drinks for men/women). Lower and Upper CI represent bootstrapped 95% confidence intervals; bolded effects are statistically significant. Predictors in top panel are held constant across thresholds. All effects are within-person at the daily level, with the exception of Age, Sex, AUD/CUD, and % of marijuana use days, which were between-person. AUD may be explained by reduced inhibitory control from using marijuana (Metrik et al., 2012; Ramaekers et al., 2006) . This potential for impaired control over drinking may in turn contribute to more alcohol-related problems, as decline in executive functioning has been implicated in increased ad libitum alcohol consumption (Jones et al., 2013) . Alternatively, because individuals with AUD drink primary for negative reinforcement (Pacher et al., 2006) , marijuana may be uniquely associated with heavy alcohol use among those who rely on alcohol to cope with stress and other negative affective states in the absence of more effective coping skills (as in the current sample of OIF/OEF/OND veterans). On the other hand, for some individuals with AUD, marijuana use and alcohol consumption may be commonly paired and marijuana may be used purposefully to enhance alcohol's pleasurable effects (Lukas and Orozco, 2001; Lukas et al., 1992) . Therefore, in those with AUD, marijuana-related cues may trigger urges to drink as a learned or as a pharmacologic response to marijuana use to a greater degree than in individuals with a sole diagnosis of CUD. Indeed, individuals with CUD alone were not more likely to drink heavily on marijuana use days.
In contrast to the complementary nature of daily marijuana-alcohol associations among those with AUD, individuals with CUD diagnosis only (i.e., no AUD diagnosis) were more likely to drink at moderate drinking levels (1 to 4/3 drinks for men/women) than they were to drink heavily (≥5/ 4 drinks) when they used marijuana. Although not hypothesized, this finding indicates that demand for alcohol is diminished in the presence of marijuana but only for marijuana users without any evidence of AUD. Our finding signals potential substitution effect, although full substitution pattern (marijuana replacing alcohol) is certainly not evident in these data. Nevertheless, several lines of research have similarly suggested that marijuana use by medical marijuana users, who typically endorse stable daily or almost daily patterns of marijuana use (Lin et al., 2016; Walsh et al., 2013) , is associated with past history of alcohol misuse but lower current alcohol problem severity as compared to recreational marijuana users (Lin et al., 2016; Loflin et al., 2017) . Whether marijuana use is an effective harm-reduction strategy when used as a substitute for alcohol, at least by those without AUD, deserves further scientific investigation.
These findings have significant clinical implications. First and foremost, individuals with AUD and those with comorbid AUD and CUD disorders are a group that are high risk and may pose a significant challenge for treatment providers. For individuals with AUD including those with co-occurring CUD, our data underscore the importance of assessment and psychoeducation on the role that marijuana may play in placing an individual at greater risk for increased drinking. This public health message is important to deliver in the context of often conflicting clinical and media messages on marijuana's therapeutic potential. The present study highlights the need for both treatment and intervention programs to assess both marijuana and alcohol use on a regular and consistent basis. The findings on marijuana's association with heavy drinking can significantly impact a large proportion of individuals currently in treatment for AUD for whom use of marijuana may serve as a relapse trigger leading to increased desire to use alcohol. For these individuals, recommending marijuana cessation may improve alcohol treatment outcomes. This is particularly important because many patients seeking treatment specifically for AUD may not be aware or motivated to make concurrent changes in their marijuana use.
Limitations
The findings of the study should be considered in the context of some limitations. Despite the TLFB method's established reliability and validity, this retrospective reporting method may carry recall bias that could have influenced the observed patterns of substance use. This bias may be particularly pronounced in day-level analysis of assessment windows covering longer time intervals such as 60 days (Hoeppner et al., 2010) and is of concern with respect to the analysis of within-person, day-level association of behaviors with varying base-rate frequency (Carney et al., 1998) . Prior research also demonstrates that TLFB reports may underestimate frequency and quantity of alcohol consumed (Searles et al., 2002) . However, retrospective assessment on the TLFB has been shown not to be temporally biased; that is, reports did not change with increasing time intervals from 30 to 60 to 366 days (Searles et al., 2002) or in comparison of 30-and 180-day time intervals (Carey, 1997) . Thus, the observed associations in this study are likely stable although may be conservative estimates of the actual substance use behaviors. Temporal order between use of marijuana and alcohol cannot be established with this type of assessment. A small number of women in our sample limit the generalizability of our findings to both sexes. However, the disproportionally male composition of this sample is representative of the veteran population with men comprising 92% as reported in the national veteran surveys (National Center for Veterans Analysis and Statistics, 2017) . This was a study of associations, with future studies benefitting from a more comprehensive analysis of environmental factors such as social contextual cues . Finally, the sample, comprised of individuals residing across 3 Northeastern states, was enrolled in a single site, a VHA facility. Although a veteran population is an ideal one in which to investigate comorbidity between CUD and AUD, future multisite research should seek to confirm these findings in a broader population.
CONCLUSIONS
These findings add important information to the small body of literature on event-level associations between marijuana and alcohol use. Results suggest that heavy drinking is more likely to occur on days when marijuana is used among individuals with AUD as well as those with comorbid AUD and CUD, but not among those with a single diagnosis of CUD. Differentiating heavy from moderate drinking levels, as well as examining synergistic effects of diagnosis, clarified mixed findings from previous studies that failed to consider variability in alcohol and drug diagnoses. Marijuana users who meet criteria for AUD and CUD diagnoses appear to be at greatest risk for problem drinking on days when they also use marijuana. This level of heavy drinking is commonly associated with long-term persistent alcohol problems. An important question for future research to examine is the association between actual quantities of marijuana use and alcohol use as well as "in the moment" associations between marijuana and alcohol use with EMA data and with experimental studies on acute effects of marijuana on alcohol consumption. Real-time assessment of day-level associations between marijuana and alcohol use in EMA research would help address current concerns about the potential bias of retrospective reporting. Current findings and our ongoing studies on co-use will inform alcohol treatment efforts for comorbid CUD and AUD and help guide public health policy on this comorbidity that is more disabling, chronic, and costly to society than CUD alone.
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